Gurevičienė, G. “PD-L1 INHIBITOR PEMBROLIZUMAB – FOR FIRST LINE ADVANCED NON-SMALL CELL LUNG CANCER THERAPY”. Pulmonology and Allergology, Vol. 3, no. 2, Sept. 2019, pp. 177-82, doi:10.37499/PIA.136.